Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,000
Closed -$58.2K 366
2024
Q2
$58.2K Hold
5,000
0.03% 227
2024
Q1
$44.4K Buy
5,000
+2,000
+67% +$22.1K 0.03% 266
2023
Q4
$34K Buy
+3,000
New +$27.6K 0.02% 299

Other funds holding ETNB

Wetzel Investment Advisors's ETNB Position: Q3 2024 in Review

Wetzel Investment Advisors sold out of 89bio (ETNB) in Q3 2024, closing a stake of 5,000 shares — an estimated $58.2K sold.

Wetzel Investment Advisors first reported a position in ETNB in Q4 2023 and held it in 3 quarters. The position peaked at $58.2K in Q2 2024. 144 funds tracked by Wall St. Rank hold ETNB as of Q3 2024.

  • Wetzel Investment Advisors reported no remaining 89bio position as of Q3 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 5,000 89bio shares in Q3 2024, an estimated $58.2K.
  • Wetzel Investment Advisors first reported a position in 89bio in Q4 2023 and held it in 3 quarters.
  • Wetzel Investment Advisors's 89bio position peaked at $58.2K in Q2 2024.
  • 144 funds tracked by Wall St. Rank held 89bio as of Q3 2024.

Based on Wetzel Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.